Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
The AAPS Journal
|
February 1, 2024
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations
Angela Elma Edwina, Erwin Dreesen, Julie Hias, et al.
Pharmaceutics
|
February 26, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease
Andres J Yarur, Thierry Dervieux, Ryan Ungaro, et al.
Pharmaceutics
|
July 27, 2022
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
Heleen Gastmans, Erwin Dreesen, Sebastian G Wicha, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 23, 2021
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis
Sabrina De Winter, Reinier van Hest, Erwin Dreesen, et al.
Pharmaceutics
|
October 23, 2021
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model
Jurij Aguiar Zdovc, Jurij Hanžel, Tina Kurent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 29, 2020
Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission
Jurij Hanžel, Jurij Zdovc, Tina Kurent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Pharmacology and Therapeutics
|
August 10, 2023
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde-Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology
Dorien Bamps, Anthony James Blockeel, Erwin Dreesen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Frontiers in Immunology
|
June 27, 2022
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
E Sally Ward, Deborah Gelinas, Erwin Dreesen, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
The AAPS Journal
|
February 1, 2024
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations
Angela Elma Edwina, Erwin Dreesen, Julie Hias, et al.
Pharmaceutics
|
February 26, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease
Andres J Yarur, Thierry Dervieux, Ryan Ungaro, et al.
Pharmaceutics
|
July 27, 2022
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
Heleen Gastmans, Erwin Dreesen, Sebastian G Wicha, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 23, 2021
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis
Sabrina De Winter, Reinier van Hest, Erwin Dreesen, et al.
Pharmaceutics
|
October 23, 2021
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model
Jurij Aguiar Zdovc, Jurij Hanžel, Tina Kurent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 29, 2020
Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission
Jurij Hanžel, Jurij Zdovc, Tina Kurent, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
Clinical Pharmacology and Therapeutics
|
August 10, 2023
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde-Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology
Dorien Bamps, Anthony James Blockeel, Erwin Dreesen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Frontiers in Immunology
|
June 27, 2022
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
E Sally Ward, Deborah Gelinas, Erwin Dreesen, et al.
Page
of 11